Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-08-18 07:00 |
Valneva Provides Update on IXIARO® Supply Contract with U.S. Department of Defe…
|
English | 188.3 KB | ||
| 2022-08-18 07:00 |
Valneva fait un point sur son contrat de fourniture d’IXIARO® au département am…
|
French | 188.8 KB | ||
| 2022-08-15 07:00 |
Valneva Establishes an At-the-Market (ATM) Program on Nasdaq
|
English | 128.3 KB | ||
| 2022-08-15 07:00 |
Valneva met en place un programme « At-the-Market (ATM) » sur le Nasdaq
|
French | 131.8 KB | ||
| 2022-08-11 07:00 |
Valneva publie ses résultats financiers du premier semestre 2022 et fait un poi…
|
French | 325.7 KB | ||
| 2022-08-11 07:00 |
Valneva Reports H1 2022 Results and Provides Corporate Updates
|
English | 317.3 KB | ||
| 2022-08-08 22:45 |
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA…
|
English | 200.7 KB | ||
| 2022-08-08 22:45 |
Valneva et Pfizer lancent une étude de Phase 3 pour leur candidat vaccin contre…
|
French | 155.2 KB | ||
| 2022-08-04 18:00 |
VALNEVA - Declaration of shares and voting rights - July 31, 2022
|
English | 18.9 KB | ||
| 2022-08-04 18:00 |
VALNEVA - Déclaration d’actions et de droits de vote - 31 juillet 2022
|
French | 18.9 KB | ||
| 2022-08-01 17:45 |
Valneva confirme l’avenant au contrat d'achat avec la Commission Européenne pou…
|
French | 172.4 KB | ||
| 2022-08-01 17:45 |
Valneva Confirms Amendment of Advance Purchase Agreement with European Commissi…
|
English | 173.8 KB | ||
| 2022-07-20 18:00 |
European Commission Approves Purchase Agreement Amendment for Valneva’s Inactiv…
|
English | 198.3 KB | ||
| 2022-07-20 18:00 |
La Commission européenne approuve un avenant au contrat d'achat du vaccin inact…
|
French | 166.2 KB | ||
| 2022-07-05 18:00 |
VALNEVA - Declaration of shares and voting rights - June 30, 2022
|
English | 18.6 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
